Clinical Trials Browser

Phase 1 × Solid Tumor, Adult × 1 year × Clear all

NCT06265688 2026-05-19

First In Human Study of CX-2051 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06462794 2026-05-15

First In Human Study of CX-801 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05582850 2026-05-12

EPRAD

Phase 1 Terminated

29 enrolled 12 charts

Other solid neoplasm

Solid Tumor, Adult

NCT07159828 2026-05-06

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT05071846 2026-04-14

MVX-ONCO-2 in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05763004 2026-03-27

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04221204 2026-03-25

A Monotherapy in Subjects With Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT04928508 2026-03-05

Okgyn1

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05381909 2026-02-20

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT06507306 2026-02-06

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT07294872 2026-01-16

A Study of TIL in Advanced Solid Tumors (CZ)

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT03905148 2026-01-07

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03772561 2025-07-22

MEDIPAC

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT03990233 2025-06-26

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult